Factors regulating the transcriptional elongation activity of RNA polymerase II

FASEB Journal

Volumn 12, Issue 14, 1998, Pages 1437-1446

  Shilatifard, Ali ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ELL associated proteins transcriptional arrest; mRNA synthesis; Negative elongation factor

Indexed keywords

ELONGATION FACTOR; RNA POLYMERASE II;

DNA BINDING; DNA TRANSCRIPTION; ENZYME ACTIVITY; ENZYME REGULATION; EUKARYOTE; GENE EXPRESSION REGULATION; GENE REPRESSION; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EUKARYOTA;

EID: 0031763366     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.12.14.1437     Document Type: Review

References (85)

1. Marshall, N. F., and Price, D. H. (1995) Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270, 12335-12338
2. Yankulov, K. Y., Pandes M., McCracken, S., Bouchard, D., and Bentley, D. L. (1996) TFIIH functions in regulating transcriptional elongation by Pol II in Xenopus oocytes. Mol. Cell Biol. 16, 3291-3299
3. Brown, S. A., Imbalzano, A. N., and Kingston, R. E. (1996) Activator-dependent regulation of transcriptional pausing on nucleosomal templates. Genes & Dev. 10, 1479-1490
4. Shilatifard, A., Lane, W. S., Jackson, K. W., Conaway, R. C., and Conaway, J. W. (1996) An RNA polymerasc II elongation factor encoded by the human ELL gene. Science 271, 1873-1876
5. Shilatifard, A., Haque, D., Conaway, R. C., and Conaway, J. W. (1997) Structure and function of an RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex. J. Biol. Chem. 272, 22355-22363
6. Shilatifard, A. (1998) Identification and purification of the Holo-ELL complex. J. Biol. Chem. 273,11212-11217
7. Bradsher, J. N., Jackson, K. W., Conaway, R. C., and Cottaway, J. W. (1993) An RNA polymerase II transcription factor SIII. I. Identification, purification, and properties. J. Biol. Chem. 268, 25587-25593
8. Zhou, Q., and Sharp, P. A. (1996) Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274, 605-610
9. Orphanides, G., LeRoy, G., Chang, C. H., Luse, D. S., and Reinberg, D. (1998) FACT, a factor that facilitates transcript elongation through nucleosomes. Cell 92, 105-116
10. Wada, T.,Takagi,T.,Yamaguchi,Y.,Ferdous, A., Imai, T., Hirose, S., Sugimoto, S., Yano, K., Hartzog, G. A., Winstion, F., Buratowski, S., and Handa, H. (1998) DSIF, a novel transcription elongation factor that regulates Pol II processivity, is composed of human Spt4 and Spt5 homologs. Genes & Dev. 12, 343-356
11. Hartzog, G. A., Wada, T., Handa, H., and Winston, F. (1998) Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerasc II in Saccharomyces cerevisiae. Genes & Dev. 12 357-369
12. Peng, J. Zhu, Y., Milton, J. T., and Price, D. H. (1998) Identification of multiple cyclin subunits of human P-TEFb. Genes & Dev. 12, 755-762
13. Xie, Z., and Price, D. H. (1996) Purification of an RNA polymerase II transcript release factor from Drosophila.J. Biol. Chem. 271, 11043-11046
14. Grunstein, M. (1997) Histone acetylation in chromatin structure and transcription. Nature (London) 389, 349-352
15. Tsukiyama, T., and Wu, C. (1997) Chromatin remodeling and transcription. Curr. Opin. Genet. Dev. 7, 182-191
16. Edmondson, D., and Roth, S. (1996) Chromatin and transcription. FASEB J. 10,1173-1182
17. Winstion, F., and Carlson, M. (1992) Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet. 8, 387-391
18. Wolffe, A. P. (1997) Transcription control: repressed repeats express themselves. Curr. Biol. 7,796-798
19. Kadonaga, J. T. (1998) Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 92, 307-313
20. Peterson, C. L. (1996) Multiple switches to turn on chromatin? Curr. Opin. Genet. Dev. 6, 171-175
21. Kornberg, R. D., and Lorch, Y. (1995) Interplay between chromatin structure and transcription. Curr. Opin. Cell. Biol. 7, 371-375
22. Bayle, J. H., and Crabtree, G. R. (1997) Protein acetylation: more than chromatin modification to regulate transcription. Chem. Biol. 12, 885-888
23. Izban. M. G., and Luse, D. S. (1992) Factor-stimulated RNA polymerase II transcribes at physiological elongation rates on naked DNA but very poorly on chromatin templates. J. Biol. Chem. 207, 13647-13655
24. Tennyson, C. N., Klamut, H. J., and Worton, R. G. (1995) The human dystrophin gone requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat. Genet. 9, 184-190
25. Ucker, D. S., and Yamamoto, K. R. (1984) Early events in the stimulation of mammary tumor virus RNA synthesis by glucocorticoids. Novel assays of transcription rates. J. Biol. Chem. 259, 7416-7420
26. Thummel, C. S., Burtis, K. C., and Hogness, D. D. (1990) Spatial and temporal patterns of E74 transcription during Drosophila development. Cell 61, 101-111
27. Reines, D., Conaway, J. W., and Conaway, R. C. (1996) The RNA polymerase II general elongation factors. Trends Biochem. Sci. 21, 351-355
28. Uptain, S., Kane, C. M., and Chamberlin, M. J. (1997) Basic mechanisms of transcript elongation and its regulation. Annu. Rev. Biochem. 66, 117-172
29. Sekimizu, K., Kobayashi, N., Mizuno, D., and Natori, S. (1976) Purification of a factor from Ehrlich ascites tumor cells specifically stimulating Pol II. Biochemistry 15, 5064-5070
30. Rudd, M. D., Izban, M., and Luse, D. S. (1994) The active site of RNA polymerase II participates in transcript cleavage within arrested ternary complexes. Proc. Natl. Acad, Sci. USA 91, 8057-8061
31. Reines, D., and Mote, J. (1993) Elongation factor SII-dependcnt transcription by an RNA polymerase II through a sequence-specific DNA-binding protein. Proc. Natl. Acad. Sci. USA 90,1917-1921
32. Price, D. H., Sluder, A. E., and Greenleaf, A. L. (1989) Dynamic interaction between a Drosophila transcription factor and RNA polymerase II. Mol. Cell. Biol. 9, 1465-1475
33. Gu, W., and Reines, D. (1995) Identification of a decay in transcription potential that results in elongation factor dependence of Pol II.J. Biol. Chem. 270, 11238-11244
34. Garrett, K. P., Tan, S., Bradsher, J. N., Lane, W. S., Conaway, J. W., and Conaway, R. C. (1994) Molecular cloning of an essential subunit of an RNA polymerase II elongation factor SIII. Proc. Natl. Acad. Sci. USA 91, 5237-5241
35. Garrett, K. P., Aso, T., Bradsher, J. N., Foundling S. I., Lane, W. S., Conaway, R. C., and Conaway, J. W. (1995) Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc. Natl. Acad. Sci. USA 92, 7172-7176
36. Shilatifard, A., Duan, R. D., Haque, D., Florence, C., Schubach, W. H., Conaway, J. W., and Conaway, R. C. (1997) ELL2, a new member of an ELL family of an RNA polymerase II elongation factors. Proc. Natl. Acad. Sci. USA 94, 3639-3643
37. Duan, D. R., Pause, A., Burgess, W. H., Aso, T., Chen, D. Y., Garrett, K. P., Conaway, R. C., Conaway, J. W., Linehan, W. M., and Klausner, R. D. (1995) Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269, 1402-1406
38. Zhu, Y., Peery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M. B., and Price, D. H. (1997) Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes & Dev. 11, 2622-2632
39. Mancebo, H. S., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D., Price, D., and Flores, O. (1997) P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes & Dev. 11, 2633-2644
40. Chodosh, L. A., Fire, A., Samuels, M., and Sharp, P. A. (1989) 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits tran- scription elongation by Pol II in vitro. J. Biol. Chein. 264, 2250-2257
41. Sehgal, P. B., Derman, E., Molloy, G. R., Tamm, I., and Darnell, J. E. (1976) 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inliibits initiation of nuclear heterogeneous RNA chains in HeLa cells. Science 22, 431-433
42. Tamm, I., and Kikuchi, T. (1979) Early termination of heterogeneous nuclear RNA transcripts in mammalian cells: accentuation by 5,6-dichloro 1-beta-D-ribofuranosylbenzimidazole.Proc. Natl. Acad. Sci. USA 76, 5750-5754
43. Winston, F., and Carlson, M. (1992) Yeast Snf/Swi transcriptional activators and the Spi/Sin chromatin connection. Trends Genet. 8, 387-391
44. Swanson, M. S., Malone, E. A., and Winston, F. (1991) Spt5, an essential gene important for normal transcription in Saccharomyces cerevisiae, encodes an acidic nuclear protein with a carboxyterminal repeat. Mol. Cell. Biol. 11, 3009-3019
45. Malagon, F., and Aguilera, A. (1996) Differential intrachromosomal hyper-recombination phenotype of spt4 and spt6 mutants in S. cerevisiae. Curr. Genet. 30, 101-106
46. Basrai, M. A., Kingsbury,J., Koshland, D. Spencer, F., and Hieter, P. (1996) Faithful chromosome transmission requires Spt4, a putative regulator of chromatin structure in Saccharomyces cerevisiae. Mol. Cell. Biol. 16,2838-2847
47. Xie, Z., and Price, D. H. (1998) Unusual nucleic acid binding properties of factor 2, an Pol II transcript release factor. J. Biol. Chem. 273, 3771-3777
48. Marshall, N. F., Peng J., Xie, Z., and Price, D. H. (1996) Control of RNA polymerase II elongation potential by a novel carboxylterminal domain kinase.J. Biol. Chem. 271, 27176-27183
49. Wei, P., Garber, M. E., Fang, S.-M., Fischer, W. H., and Jones, K. A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA Cell 92, 451-462
50. McCracken, S., Fong, N., Yankulov, K., Ballantyne, S., Pan, G., Greenblatt, J., Patterson, S. D., Wickens, M., and Bentley, D. L. (1997) The C-terminal domain of Pol II couples mRNA processing to transcription. Nature (London) 385, 357-361
51. Kassavetis, G. A., and Chamberlin, M.J. (1981) Pausing and termination of transcription within the early region of bacteriophage T7 DNA in vitro. J. Biol. Chem. 256, 2777-2786
52. Spencer, C. A., and Groudine, M. (1990) Transcription elongation and eukaryotic gene regulation. Oncogene 5, 777-785
53. Wright, S. (1993) Regulation of eukaryotic gene expression by transcriptional attenuation. Mol. Biol. Cell 4, 661-668
54. Donahue, B. A., Yin, S., Taylor, J. S., Reines, D., and Hanawalt, P. C. (1994) Transcript cleavage by Pol II arrested by a cyclobutane pyrimidine dimer in the DNA template. Proc. Natl. Acad. Sci. USA 91, 8502-8506
55. Reeder, T. C., and Hawley, D. K., (1996) Promoter-proximal sequences modulates Pol II elongation by a novel mechanism. Cell 87, 767-777
56. Thomas, M. J., Platas, A. A., and Hawley, D. K. (1998) Transcriptional fidelity and proofreading by Pol II. Cell 93, 627-637
57. Kornberg, R. D., and Lorch, Y. (1991) Irresistible force meets immovable object: transcription and the nucleosome. Cell 67, 833-836
58. Felsenfeld, G. (1992) Chromatin as an essential part of the transcriptional mechanism. Nature (London) 355, 219-224
59. Chang, C.-H., and Luse, D. S. (1997) The H3/H4 tetramer blocks transcript elongation by Pol II in vitro. J. Biol. Chem. 272, 23427-23434
60. Clark, D. J., and Felsenfeld, G. (1992) A nucleosome core is transferred out of the path of a transcribing polymerase. Cell 71, 11-22
61. Studitsky, V. M., Clark, D. J., and Felsenfeld, G. (1994) A histone octamer can step around a transcribing polymerase without leaving the template. Cell 76, 371-382
62. Studitsky, V. M., Kassavetis, G. A., Geiduschek, E. P., and Felsenfeld, G. (1997) Mechanism of transcription through the nucleosome by eukaryotic RNA polymerase. Science 278, 1960-1963
63. Gnarra, J. R., Duan. D. R., Weng, Y., Humphrey, J. S., Chen, D. Y., Lee, S., Pause, A., Dudley, C. F., Latif, F., Kuzmin, I., Schmidt, L., Duh, F. M., Stackhouse, T., Chen, F., Kishida, T., Wei, M. H., Lerman, M. I., Zbar, B., Klausner, R. D., and Linehan, W. M. (1996) Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim. Biophys. Acta 1242, 201-210
64. Sekido, Y., Bader, S., Latif, F., Gnarra, J. R., Gazdar, A. F., Linehan, W. M., Zbar, B., Lerman, M. I., and Minna, J. D. (1994) Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 9,1599-1604
65. 64a. Conaway, W. J., Kamura, T., and Conaway, R. C. (1998) The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein. Biochim. Biophys. Acta 1377, M49-M54
66. Pause, A., Lee, S., Worrell, R. A., Chen, D. Y. T., Burgess, W. H., Linehan, W. M., and Klausner, R. D. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins (1997) Proc. Natl. Acad. Sci. USA 94, 2156-2161
67. Lonergan. K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R. C., Conaway,J. W., and Kaelin, W. G., Jr. (1998) Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. (1998) Mol. Cell. Biol. 18, 732-741
68. Thirman, M. J., Levitan, D. A., Kobayashi, H., Simon, M. C., and Rowley, J. D. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23'3.1) in acute myeloid leukemia (1994) Proc. Natl. Acad. Sci. USA 91, 12110-12114
69. Mitani, K. Kanda, Y., Ogawa, S., Tanaka, T., Inazawa, J., Yazaki, Y.,and Hirai, H. (1995) Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.l) translocation. Blood 85, 2017-2024
70. Tkachuk, D. C., Kohler, S., and Cleary, M. L. (1992) Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71, 691-700
71. Gu,Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C. M., and Canaani, E. (1992) The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71, 701-708
72. Rabbitts T. H. (1994) Chromosomal translocations in human cancer. Nature (London) 372, 143-149
73. Yu, B. D., Hess, J. L., Horning, S. E., Brown, G. A., and Korsmeyer, S. J. (1995) Altered Hox expression and segmental identity in Mil-mutant mice. Nature (London) 378, 505-508
74. So C. W., Caldas, C., Liu, M. M., Chen, S. J., Huang, Q. H., Gu, L. J., Sham, M. H., Wiedemann, L. M., and Chan, L. C. (1997) EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc. Natl. Acad. Sci. USA 94, 2563-2568
75. Prasad, R., Yano, T., Sorio, C., Nakamura, T., Rallapalli, R., Gu, Y., Leshkowitz, D., Croce, C. M., and Canaani, E. (1995) Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc. Natl. Acad. Sci. USA 92,12160-12164
76. Rubnitz, J. E., Morrissey, J., Savage, P. A., and Cleary, M. L. (1994) ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 84,1747-1752
77. Joh, T., Yamamoto, K., Kagami, Y., Kakuda, H., Sato, T., Yamamoto, T., Takahashi, T., Ueda, R., Kaibuchi, K., and Seto, M. (1997) Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus. Oncogene 15,1681-1687
78. Super, H. G., Strissel, P. L., Sobulo, O. M., Burian, D. Reshmi, S. C., Roe, B., Zeleznik-Le, N.J., Diaz, M. O., and Rowley,J. D. (1997) Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosomes Cancer 20,185-195
79. Hjorth-Sorensen, B., Pallisgaard, N., Gronholm, M., Hokland, P., Clausen, N., and Jorgensen, P. (1997) A novel MLL-AF10 fusion mRNA variant in a patient with acute myeloid leukemia detected by a new asymmetric reverse transcription PCR method. Leukemia 11, 1588-1593
80. Borkhardt, A., Repp, R., Haas, O. A., Leis, T., Harbott, J., Kreuder, J., Hammermann, J., Henn, T., and Lampert, F. (1997) Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemia with a t(X;11) (q13;q23). Oncogene 14, 195-202
81. Corral, J., Lavenir, I., Impey, H., Warren, A. J., Forster, A., Larson, T. A., Bell, S., McKenzie, A. N.J., King, G., and Rabbitts, T. H. (1996) An M11-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes. Cell 85, 853-861
82. Willott, E., Balda, M. S., Fanning, A. S., Jameson, B., van Itallie, C., and Anderson J. M. (1993) The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions. Proc. Natl. Acad. Sci. USA 90, 7834-7838
83. Furuse, M., Itoh, M., Hirase, T., Nagafuchi, A., Yonemura, Tsukita, S., and Tsukita, S. (1994) Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J. Cell Biol. 127, 1617-1626
84. Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., and Tsukita, S. (1993) Occludin: A novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123, 1777-1788
85. Gottardi, C. J., Arpin, M., Fanning, A. S., and Louvard, D. (1996) The junction-associated protein zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc. Natl. Acad. Sci. USA 93,10779-10784